By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Acceleron Pharma 

128 Sidney Street

Cambridge  Massachusetts    U.S.A.
Phone: 617-649-9200 Fax: 617-649-9988


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Alkermes 





Company News
Acceleron Pharma To Webcast Conference Call Of Second Quarter 2016 Financial Results On August 4, 2016 7/28/2016 11:37:14 AM
Acceleron Pharma Appoints Thomas Mccourt To Its Board Of Directors 7/26/2016 10:39:17 AM
Acceleron Pharma Announces ACE-083 Phase 1 Results At The 14th International Congress On Neuromuscular Diseases 7/8/2016 10:37:02 AM
Acceleron Pharma And Celgene (CELG) Announce Updated Results From An Ongoing Phase II Study Of Luspatercept In Myelodysplastic Syndromes At The 21st Congress Of The European Hematology Association 6/10/2016 7:52:08 AM
Acceleron Pharma And Celgene (CELG) Announce Updated Results From An Ongoing Phase II Study Of Luspatercept In Beta-Thalassemia Presented At The 21st Congress Of The European Hematology Association 6/10/2016 7:47:36 AM
Acceleron Pharma To Host Conference Call And Webcast To Review Updated Luspatercept Results Presented At The 21st Congress Of The European Hematology Association 6/8/2016 10:26:15 AM
Acceleron Pharma To Participate In Two Healthcare Investor Conferences In June 6/1/2016 4:59:43 PM
Acceleron Pharma Announces Data Presentations With Luspatercept At The 21st Congress Of The European Hematology Association 5/19/2016 12:20:24 PM
Acceleron Pharma Reports First Quarter 2016 Financial And Operational Results 5/5/2016 10:55:09 AM
Acceleron Pharma To Host First Quarter 2016 Financial Results 4/29/2016 10:25:03 AM
12345678910...
//-->